Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 37.65
Bid: 37.20
Ask: 37.50
Change: -0.125 (-0.33%)
Spread: 0.30 (0.806%)
Open: 37.30
High: 37.65
Low: 37.00
Prev. Close: 37.475
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Major Interest in Shares

31 Mar 2015 17:05

RNS Number : 0690J
Futura Medical PLC
31 March 2015
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

Futura Medical plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation:

Henderson Global Investors

4. Full name of shareholder(s)  (if different from 3.):

5. Date of the transaction and date onwhich the threshold is crossed orreached:

30 March 2015

6. Date on which issuer notified:

31 March 2015

7. Threshold(s) that is/are crossed orreached:

Above 16%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary

14,859,126

14,859,126

15,914,126

16.07%

GB0033278473

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

15,914,126

16.07%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

This disclosure has been calculated based on total voting rights amount of 99,022,600.

14. Contact name:

Scott Dickenson

15. Contact telephone number:

020 7818 4184

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLWGUWUWUPAGQG
Date   Source Headline
25th May 200710:33 amRNSNotice of Preliminary Results
17th May 20077:01 amRNSHolding(s) in Company
14th May 20077:02 amRNSMED2002 Update
9th May 20077:02 amRNSCSD500 Patents granted
4th May 20077:01 amRNSConference Presentation
18th Apr 20077:01 amRNSDermaSys Agreement with GSK
22nd Mar 200711:02 amRNSHolding(s) in Company
20th Mar 20077:01 amRNSHolding(s) in Company
28th Feb 20077:01 amRNSLaunch of DermaSys Brand
31st Jan 20078:00 amRNSAdditional Listing
18th Jan 200712:52 pmRNSHolding(s) in Company
20th Dec 20067:01 amRNSTotal Voting Rights
16th Nov 20067:01 amRNSCSD500 Regulatory Update
12th Oct 20067:00 amRNSTechnical Seminar
21st Sep 20067:01 amRNSInterim Results
7th Sep 20067:00 amRNSNotice of Interim Results
6th Sep 20067:01 amRNSDCF100 Skin Study Results
17th Jul 20067:00 amRNSFLD500 Scale-up Trials
6th Jul 20067:01 amRNSNew Product Update
4th Jul 20062:44 pmRNSIssue of Equity
4th Jul 20062:39 pmRNSAgreement with GSK
27th Jun 20061:01 pmRNSHolding(s) in Company
21st Jun 200611:13 amRNSComment on Press Speculation
22nd May 20067:01 amRNSPreliminary Results
9th May 20067:00 amRNSUpdate on MED2002
6th Feb 200611:34 amRNSAdditional Listing
1st Feb 20067:00 amRNSAdditional Listing
3rd Jan 200612:50 pmRNSHolding(s) in Company
21st Dec 20054:14 pmRNSAdditional Listing
9th Dec 20057:01 amRNSRe: Global Rights
30th Nov 200510:18 amRNSAdditional Listing
28th Nov 20057:01 amRNSEU Marketing Submission
21st Nov 20057:02 amRNSStudy Results
7th Nov 20057:00 amRNSStudy Results
5th Sep 20057:00 amRNSInterim Results
12th Aug 20057:00 amRNSProduct development update
19th Jul 200511:00 amRNSNotice of Results
6th Jul 20057:00 amRNSSSL acquires rights to FLD500
5th Jul 200510:45 amRNSHolding(s) in Company
6th Jun 20053:38 pmRNSNotice of AGM
17th May 20052:44 pmRNSHolding(s) in Company
25th Apr 20057:00 amRNSManufacturing trials
22nd Mar 200510:11 amRNSGrant of options
21st Mar 20057:01 amRNSFinal Results
18th Mar 200512:58 pmRNSNotice of Results
28th Feb 20051:06 pmRNSChange of Advisers
1st Feb 20054:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.